Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Gabbard AP, Booth GS. Cold agglutinin disease. Clin Hematol Int. 2020;2(3):95–100.
2. Berentsen S, Röth A, Randen U, et al. Cold agglutinin disease: current challenges and future prospects. J Blood Med. 2019;10:93–103.
3. Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, et al. Autoimmune hemolytic anemia: current knowledge and perspectives. Immunity Ageing. 2020;17(1):38.
4. Barcellini W, Zaninoni A, Giannotta JA, et al. New insights in autoimmune hemolytic anemia: from pathogenesis to therapy stage 1. J Clin Med. 2020;9:12.
5. Sanofi. FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease [media release]. 4 Feb 2022. https://www.sanofi.com/en/media-room/press-releases/2022/2022-02-04-23-00-00-2379517.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献